Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and Dengue virus.

Varga N, Sutkeviciute I, Ribeiro-Viana R, Berzi A, Ramdasi R, Daghetti A, Vettoretti G, Amara A, Clerici M, Rojo J, Fieschi F, Bernardi A.

Biomaterials. 2014 Apr;35(13):4175-84. doi: 10.1016/j.biomaterials.2014.01.014. Epub 2014 Feb 6.

PMID:
24508075
[PubMed - in process]
2.

Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.

Garcia-Vallejo JJ, Koning N, Ambrosini M, Kalay H, Vuist I, Sarrami-Forooshani R, Geijtenbeek TB, van Kooyk Y.

Int Immunol. 2013 Apr;25(4):221-33. doi: 10.1093/intimm/dxs115. Epub 2013 Jan 4.

PMID:
23291968
[PubMed - indexed for MEDLINE]
3.

Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides.

Arnáiz B, Martínez-Ávila O, Falcon-Perez JM, Penadés S.

Bioconjug Chem. 2012 Apr 18;23(4):814-25. doi: 10.1021/bc200663r. Epub 2012 Mar 30.

PMID:
22433013
[PubMed - indexed for MEDLINE]
4.

Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design.

Thépaut M, Guzzi C, Sutkeviciute I, Sattin S, Ribeiro-Viana R, Varga N, Chabrol E, Rojo J, Bernardi A, Angulo J, Nieto PM, Fieschi F.

J Am Chem Soc. 2013 Feb 20;135(7):2518-29. doi: 10.1021/ja3053305. Epub 2013 Feb 8.

PMID:
23360500
[PubMed - indexed for MEDLINE]
5.

Unique DC-SIGN clustering activity of a small glycomimetic: A lesson for ligand design.

Sutkeviciute I, Thépaut M, Sattin S, Berzi A, McGeagh J, Grudinin S, Weiser J, Le Roy A, Reina JJ, Rojo J, Clerici M, Bernardi A, Ebel C, Fieschi F.

ACS Chem Biol. 2014 Jun 20;9(6):1377-85. doi: 10.1021/cb500054h. Epub 2014 May 6.

PMID:
24749535
[PubMed - in process]
6.

Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection.

Luczkowiak J, Sattin S, Sutkevičiūtė I, Reina JJ, Sánchez-Navarro M, Thépaut M, Martínez-Prats L, Daghetti A, Fieschi F, Delgado R, Bernardi A, Rojo J.

Bioconjug Chem. 2011 Jul 20;22(7):1354-65. doi: 10.1021/bc2000403. Epub 2011 Jun 20.

PMID:
21650462
[PubMed - indexed for MEDLINE]
7.

Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin.

Spear GT, Zariffard MR, Xin J, Saifuddin M.

Immunology. 2003 Sep;110(1):80-5.

PMID:
12941144
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN.

Martínez-Avila O, Hijazi K, Marradi M, Clavel C, Campion C, Kelly C, Penadés S.

Chemistry. 2009 Sep 28;15(38):9874-88. doi: 10.1002/chem.200900923.

PMID:
19681073
[PubMed - indexed for MEDLINE]
9.

Noncarbohydrate glycomimetics and glycoprotein surrogates as DC-SIGN antagonists and agonists.

Prost LR, Grim JC, Tonelli M, Kiessling LL.

ACS Chem Biol. 2012 Sep 21;7(9):1603-8. Epub 2012 Jul 19.

PMID:
22747463
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.

Hoorelbeke B, Xue J, LiWang PJ, Balzarini J.

PLoS One. 2013 May 31;8(5):e64132. doi: 10.1371/journal.pone.0064132. Print 2013.

PMID:
23741304
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

DC-SIGN increases the affinity of HIV-1 envelope glycoprotein interaction with CD4.

Hijazi K, Wang Y, Scala C, Jeffs S, Longstaff C, Stieh D, Haggarty B, Vanham G, Schols D, Balzarini J, Jones IM, Hoxie J, Shattock R, Kelly CG.

PLoS One. 2011;6(12):e28307. doi: 10.1371/journal.pone.0028307. Epub 2011 Dec 7.

PMID:
22163292
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models.

Berzi A, Reina JJ, Ottria R, Sutkeviciute I, Antonazzo P, Sanchez-Navarro M, Chabrol E, Biasin M, Trabattoni D, Cetin I, Rojo J, Fieschi F, Bernardi A, Clerici M.

AIDS. 2012 Jan 14;26(2):127-37. doi: 10.1097/QAD.0b013e32834e1567.

PMID:
22045343
[PubMed - indexed for MEDLINE]
13.

DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission.

Geijtenbeek TB, van Kooyk Y.

Curr Top Microbiol Immunol. 2003;276:31-54. Review.

PMID:
12797442
[PubMed - indexed for MEDLINE]
14.

Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor.

Snyder GA, Ford J, Torabi-Parizi P, Arthos JA, Schuck P, Colonna M, Sun PD.

J Virol. 2005 Apr;79(8):4589-98.

PMID:
15795245
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals.

Lozach PY, Burleigh L, Staropoli I, Navarro-Sanchez E, Harriague J, Virelizier JL, Rey FA, Desprès P, Arenzana-Seisdedos F, Amara A.

J Biol Chem. 2005 Jun 24;280(25):23698-708. Epub 2005 Apr 26.

PMID:
15855154
[PubMed - indexed for MEDLINE]
Free Article
16.

Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside.

Varga N, Sutkeviciute I, Guzzi C, McGeagh J, Petit-Haertlein I, Gugliotta S, Weiser J, Angulo J, Fieschi F, Bernardi A.

Chemistry. 2013 Apr 8;19(15):4786-97. doi: 10.1002/chem.201202764. Epub 2013 Feb 18.

PMID:
23417900
[PubMed - indexed for MEDLINE]
17.

Bifunctional CD4-DC-SIGN fusion proteins demonstrate enhanced avidity to gp120 and inhibit HIV-1 infection and dissemination.

Du T, Hu K, Yang J, Jin J, Li C, Stieh D, Griffin GE, Shattock RJ, Hu Q.

Antimicrob Agents Chemother. 2012 Sep;56(9):4640-9. doi: 10.1128/AAC.00623-12. Epub 2012 Jun 11.

PMID:
22687513
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses.

Dakappagari N, Maruyama T, Renshaw M, Tacken P, Figdor C, Torensma R, Wild MA, Wu D, Bowdish K, Kretz-Rommel A.

J Immunol. 2006 Jan 1;176(1):426-40.

PMID:
16365436
[PubMed - indexed for MEDLINE]
Free Article
19.

Proteomic analysis of DC-SIGN on dendritic cells detects tetramers required for ligand binding but no association with CD4.

Bernhard OK, Lai J, Wilkinson J, Sheil MM, Cunningham AL.

J Biol Chem. 2004 Dec 10;279(50):51828-35. Epub 2004 Sep 22.

PMID:
15385553
[PubMed - indexed for MEDLINE]
Free Article
20.

Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression.

Borggren M, Repits J, Kuylenstierna C, Sterjovski J, Churchill MJ, Purcell DF, Karlsson A, Albert J, Gorry PR, Jansson M.

Retrovirology. 2008 Mar 27;5:28. doi: 10.1186/1742-4690-5-28.

PMID:
18371209
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk